The leadership team at Decibel Therapeutics has a wealth of experience in the pharmaceutical industry, with a focus on genomics and biochemical research. Stanford University and Harvard University provide the team with a strong foundation in molecular pharmacology and biochemical sciences, respectively. This background has allowed the team to successfully develop groundbreaking treatments for hearing loss and other debilitating conditions.
View all